Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37967
CAS Number:
152459-95-5
Imatinib
Purity:
≥ 98 % (HPLC)
Documents
$56.99 /100 mg
Taille
Request Bulk Quote
Informations sur le produit

Conserver sous gaz inerte

Numéro CAS 
152459-95-5
Formule moléculaire
C29H31N7O
Poids moléculaire 
493.62
Point de fusion 
207 - 211 °C
Informations générales
Numéro CAS 
152459-95-5
Formule moléculaire
C29H31N7O
Poids moléculaire 
493.62
Point de fusion 
207 - 211 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Imatinib is widely utilized in research focused on

  • Cancer Treatment: Primarily known for its effectiveness in treating chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs), Imatinib targets specific tyrosine kinases, offering a targeted approach that minimizes damage to healthy cells compared to traditional chemotherapy.
  • Research on Drug Resistance: Researchers use Imatinib to study mechanisms of drug resistance in cancer cells, providing insights into how tumors adapt and develop resistance, which can lead to the development of new therapeutic strategies.
  • Combination Therapies: Imatinib is often tested in combination with other drugs to enhance treatment efficacy. This application is crucial in oncology, as it may improve outcomes for patients who do not respond to single-agent therapies.
  • Pharmacogenomics: The drug is used in studies examining genetic variations that affect patient responses to treatment, helping to personalize cancer therapy based on individual genetic profiles.
  • Development of New Inhibitors: Researchers leverage the knowledge gained from Imatinib's mechanism of action to design and develop new inhibitors that target similar pathways, potentially leading to more effective treatments for various cancers.

Citations